Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 5:01 pm Purchase | 13G | Verastem Inc. VSTM | Vivo Opportunity LLC | 1,538,461 6.100% | 1,538,461 (New Position) | View |
2024-02-13 5:00 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Vivo Opportunity LLC | 2,482,727 4.500% | 801,528 (+47.68%) | View |
2023-02-13 5:49 pm Purchase | 13G | GERON CORP GERN | Vivo Opportunity LLC | 26,901,882 4.300% | 4,044,739 (+17.70%) | View |
2023-02-13 5:45 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Vivo Opportunity LLC | 1,678,207 4.200% | 378,207 (+29.09%) | View |
2023-02-13 5:42 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC AVDL | Vivo Opportunity LLC | 2,251,663 3.600% | -149,613 (-6.23%) | View |
2023-02-13 5:40 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Vivo Opportunity LLC | 1,681,199 6.800% | 681,199 (+68.12%) | View |
2022-09-08 4:00 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Vivo Opportunity LLC | 1,000,000 7.100% | 1,000,000 (New Position) | View |
2022-04-08 4:00 pm Purchase | 13G | GERON CORP GERN | Vivo Opportunity LLC | 22,857,143 5.900% | 22,857,143 (New Position) | View |
2022-02-11 5:21 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC AVDL | Vivo Opportunity LLC | 2,401,276 4.100% | -481,548 (-16.70%) | View |
2021-09-30 4:30 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Vivo Opportunity LLC | 1,300,000 7.700% | 1,300,000 (New Position) | View |
2021-02-12 4:30 pm Sale | 13G | GENOCEA BIOSCIENCES INC NE GNCA | Vivo Opportunity LLC | 613,437 1.200% | -830,401 (-57.51%) | View |
2021-02-12 4:30 pm Sale | 13G | Verastem Inc. VSTM | Vivo Opportunity LLC | 0 0.000% | -6,654,632 (Position Closed) | View |
2021-02-12 4:30 pm Sale | 13G | MEI PHARMA INC PAR $ MEIP | Vivo Opportunity LLC | 3,300,330 2.800% | -7,372,117 (-69.08%) | View |
2020-03-11 5:10 pm Purchase | 13G | Verastem Inc. VSTM | Vivo Opportunity LLC | 6,654,632 4.800% | 6,654,632 (New Position) | View |
2020-03-04 4:30 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC AVDL | Vivo Opportunity LLC | 2,882,824 6.200% | 2,882,824 (New Position) | View |
2020-02-13 5:53 pm Sale | 13G | GENOCEA BIOSCIENCES INC NE GNCA | Vivo Opportunity LLC | 1,443,838 3.000% | -6,736,162 (-82.35%) | View |
2020-02-13 5:11 pm Sale | 13G | ACER THERAPEUTICS INC. ACER | Vivo Opportunity LLC | 0 0.000% | -579,051 (Position Closed) | View |
2020-02-13 4:30 pm Purchase | 13G | MEI PHARMA INC PAR $ MEIP | Vivo Opportunity LLC | 10,672,447 9.990% | 3,419,698 (+47.15%) | View |
2020-02-13 4:30 pm Sale | 13G | XENON PHARMACEUTICALS INC XENE | Vivo Opportunity LLC | 881,310 2.900% | -524,166 (-37.29%) | View |
2019-11-25 5:29 pm Purchase | 13G | Sierra Oncology Inc. SRRA | Vivo Opportunity LLC | 58,215,390 15.100% | 58,215,390 (New Position) | View |